Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 98, pseudogene (RNU1-98P) is a **pseudogene**, classified as a non-functional segment of DNA that resembles the functional U1 small nuclear RNA (snRNA) genes but has lost its protein-coding or RNA-coding ability or is otherwise no longer expressed as a functional product[1][7]. RNU1-98P belongs to a large family of U1 snRNA pseudogenes scattered throughout the human genome, some of which may be transcribed and produce variant snRNAs that participate in mRNA processing and modulation of gene expression, though the function of most individual pseudogenes like RNU1-98P remains uncharacterized[2][5]. This locus is not considered a therapeutic target, has no known drug interactions or safety concerns, is not established as a biomarker, and has no known direct disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 98, pseudogene (RNU1-98P).